Overall, these findings contribute to a better understanding of the pathophysiology of tumor-associated macrophages (TAMs) and PD-L1 and may help to identify potential targets for improved therapeutic strategies in breast cancer and brain metastases. This evidence concerns the gene CD274 and breast cancer.